Log in to post a reply
Sep 23, 2017 02:42PM
Sep 24, 2017 07:35AM
Thanks all. I am going to the Tokyo for Autologous Immune Enhancement Therapy. It is sometimes referred to as natural killer cell therapy because that is one key and unchanging component of the procedure, but the type of AIET I will pursue has at least 15 components, each tunable to how your immune system and the cancer presents.
When I was researching the treatment in the spring of this year, the resident cancer microbiologist on Inspire, Fighterm, started a thread in response to questions I directed to her about this particularly treatment.
Early on in the Inspire thread I post about specifics of the treatment and a while later I follow up with some more details and references. You can find it all there along with comments and discussion. I'll keep posting over there becauseI know that fighterm will step in an correct any mis-statements I make if I post on that thread. I find immunotherapy terribly confusing.
The abscopal effect is when the immune system starts working against cancer. In the US we are (slowly) recognizing that the abscopal can be triggered by low dose radiation treatments like SBRT buy we don't know why. We treat it like a fortuitous but random event. AIET seeks to achieve the abscopal effect, deliberately. They treat cancer as a disease of the immune system and they treat the immune system, not the cancer.
I will document how this treatment goes and I am happy to share, but I will most likely put it together after it is over more like a single case study rather than a series of posts in a thread. In the meantime, you will get random complaints and observations while I travel in an extremely foreign land, dodging intercontinental missiles, with an 11 year old. Airfare to Japan was cheap and available on short notice. Thanks Kim Jong-un!
Ibrance/Letrozol Feb '16 -Sep '17. Adoptive Cell Therapy Oct 2017. Jan 2018 SBRT to sternum met and liver mets. Jan 2018 start Faslodex.
12/28/2015, IDC, Left, 4cm, Stage IV, metastasized to bone/liver, Grade 3, ER+/PR-, HER2-
1/16/2016 Femara (letrozole)
2/2/2016 Ibrance (palbociclib)